Medifast Inc (MED) stock

MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 10/3064% below fair value

$12.97+0.11 (+0.86%)

Close on Nov 13, 2026Market cap $145.04MP/E –Yield 0.00%

Medifast EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Medifast's EV/EBITDA was 0.8× on Dec 31, 2024, against 3.5× a year earlier. Over the last 5 years it ranged from 0.7× to 22.1×, with a median of 8.0×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2024	Dec 31, 2024	0.8×	−2.7
2023	Dec 29, 2023	3.5×	−2.1
2022	Dec 30, 2022	5.7×	−5.1
2021	Dec 31, 2021	10.8×	−7.1
2020	Dec 31, 2020	17.9×	+5.9
2019	Dec 31, 2019	12.0×	−10.0
2018	Dec 31, 2018	22.0×	+4.1
2017	Dec 29, 2017	17.9×	+4.9
2016	Dec 30, 2016	13.0×	+4.6
2015	Dec 31, 2015	8.3×	+0.5
2014	Dec 31, 2014	7.8×	+1.1
2013	Dec 31, 2013	6.7×	−4.3
2012	Dec 31, 2012	11.0×	+6.3
2011	Dec 30, 2011	4.7×	−12.8
2010	Dec 31, 2010	17.5×	–